Year |
Citation |
Score |
2022 |
Ward AR, Thomas AS, Stevenson EM, Huang SH, Keating SM, Gandhi RT, McMahon DK, Bosch RJ, Macatangay BJ, Cyktor JC, Eron JJ, Mellors JW, Jones RB. No evidence that circulating HIV-specific immune responses contribute to persistent inflammation and immune activation in persons on long-term ART. Aids (London, England). PMID 35730388 DOI: 10.1097/QAD.0000000000003301 |
0.597 |
|
2021 |
Kinloch NN, Ren Y, Alberto WDC, Dong W, Khadka P, Huang SH, Mota TM, Wilson A, Shahid A, Kirkby D, Harris M, Kovacs C, Benko E, Ostrowski MA, Del Rio Estrada PM, et al. Author Correction: HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA). Nature Communications. 12: 2958. PMID 33986282 DOI: 10.1038/s41467-021-23515-z |
0.691 |
|
2021 |
Ren Y, Huang SH, Macedo AB, Ward AR, Conce Alberto WD, Klevorn T, Leyre L, Copertino DC, Mota TM, Chan D, Truong R, Rohwetter T, Zumbo P, Dündar F, Betel D, et al. Selective BCL-X Antagonists Eliminate Infected Cells from a Primary Cell Model of HIV Latency but not from Reservoirs. Journal of Virology. PMID 33980597 DOI: 10.1128/JVI.02425-20 |
0.659 |
|
2021 |
Sarabia I, Huang SH, Ward AR, Jones RB, Bosque A. The Intact Non-Inducible Latent HIV-1 Reservoir is Established In an Primary T Cell Model of Latency. Journal of Virology. PMID 33441346 DOI: 10.1128/JVI.01297-20 |
0.71 |
|
2021 |
Kinloch NN, Ren Y, Conce Alberto WD, Dong W, Khadka P, Huang SH, Mota TM, Wilson A, Shahid A, Kirkby D, Harris M, Kovacs C, Benko E, Ostrowski MA, Del Rio Estrada PM, et al. HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA). Nature Communications. 12: 165. PMID 33420062 DOI: 10.1038/s41467-020-20442-3 |
0.754 |
|
2021 |
Stevenson EM, Ward AR, Truong R, Thomas AS, Huang SH, Dilling TR, Terry S, Bui JK, Mota TM, Danesh A, Lee GQ, Gramatica A, Khadka P, Conce Alberto WD, Gandhi RT, et al. HIV-specific T-cell responses reflect substantive in vivo interactions with antigen despite long-term therapy. Jci Insight. PMID 33400687 DOI: 10.1172/jci.insight.142640 |
0.774 |
|
2020 |
Ren Y, Korom M, Ward AR, Truong R, Chan D, Huang SH, Kovacs CC, Benko E, Safrit JT, Lee J, Garbán H, Lynch R, Jones RB. Relationships between Neutralization, Binding, and ADCC of Broadly Neutralizing Antibodies against Reservoir HIV. Journal of Virology. PMID 33115874 DOI: 10.1128/JVI.01808-20 |
0.634 |
|
2020 |
Lima NS, Takata H, Huang SH, Haregot A, Mitchell J, Blackmore S, Garland A, Sy A, Cartwright P, Routy JP, Michael NL, Appay V, Jones RB, Trautmann L. CTL Clonotypes with Higher TCR Affinity Have Better Ability to Reduce the HIV Latent Reservoir. Journal of Immunology (Baltimore, Md. : 1950). PMID 32591402 DOI: 10.4049/jimmunol.1900811 |
0.76 |
|
2020 |
Mota TM, McCann CD, Danesh A, Huang SH, Magat DB, Ren Y, Leyre L, Bui TD, Rohwetter TM, Kovacs CM, Benko E, MacLaren L, Wimpelberg A, Cannon CC, Hardy WD, et al. Integrated assessment of viral transcription, antigen presentation, and CD8+ T cell function reveal multiple limitations of class I selective HDACi during HIV-1 latency reversal. Journal of Virology. PMID 32051267 DOI: 10.1128/JVI.01845-19 |
0.741 |
|
2020 |
Ren Y, Huang SH, Patel S, Conce Alberto WD, Magat D, Ahimovic DJ, Macedo AB, Durga R, Chan D, Zale E, Mota TM, Truong R, Rohwetter T, McCann CD, Kovacs CM, et al. BCL-2 antagonism sensitizes cytotoxic t cell-resistant hiv reservoirs to elimination ex vivo. The Journal of Clinical Investigation. PMID 32027622 DOI: 10.1172/JCI132374 |
0.744 |
|
2019 |
Huang SH, McCann CD, Mota TM, Wang C, Lipkin SM, Jones RB. Have Cells Harboring the HIV Reservoir Been Immunoedited? Frontiers in Immunology. 10: 1842. PMID 31447850 DOI: 10.3389/fimmu.2019.01842 |
0.73 |
|
2018 |
Osuna CE, Lim SY, Kublin JL, Apps R, Chen E, Mota TM, Huang SH, Ren Y, Bachtel ND, Tsibris AM, Ackerman ME, Jones RB, Nixon DF, Whitney JB. Publisher Correction: Evidence that CD32a does not mark the HIV-1 latent reservoir. Nature. PMID 30315222 DOI: 10.1038/S41586-018-0611-3 |
0.534 |
|
2018 |
Macedo AB, Novis CL, De Assis CM, Sorensen ES, Moszczynski P, Huang SH, Ren Y, Spivak AM, Jones RB, Planelles V, Bosque A. Dual TLR2 and TLR7 agonists as HIV latency-reversing agents. Jci Insight. 3. PMID 30282829 DOI: 10.1172/Jci.Insight.122673 |
0.7 |
|
2018 |
Osuna CE, Lim SY, Kublin JL, Apps R, Chen E, Mota TM, Huang SH, Ren Y, Bachtel ND, Tsibris AM, Ackerman ME, Jones RB, Nixon DF, Whitney JB. Evidence that CD32a does not mark the HIV-1 latent reservoir. Nature. 561: E20-E28. PMID 30232424 DOI: 10.1038/S41586-018-0495-2 |
0.692 |
|
2018 |
Ren Y, Korom M, Truong R, Chan D, Huang SH, Kovacs CC, Benko E, Safrit JT, Lee J, Garbán H, Apps R, Goldstein H, Lynch RM, Jones RB. Susceptibility to Neutralization by Broadly Neutralizing Antibodies Generally Correlates with Infected Cell Binding for a Panel of Clade B HIV Reactivated from Latent Reservoirs. Journal of Virology. PMID 30209173 DOI: 10.1128/Jvi.00895-18 |
0.633 |
|
2018 |
Huang SH, Ren Y, Thomas AS, Chan D, Mueller S, Ward AR, Patel S, Bollard CM, Cruz CR, Karandish S, Truong R, Macedo AB, Bosque A, Kovacs C, Benko E, et al. Latent HIV reservoirs exhibit inherent resistance to elimination by CD8+ T cells. The Journal of Clinical Investigation. PMID 29355843 DOI: 10.1172/Jci97555 |
0.702 |
|
2017 |
Thomas AS, Jones KL, Gandhi RT, McMahon DK, Cyktor JC, Chan D, Huang SH, Truong R, Bosque A, Macedo AB, Kovacs C, Benko E, Eron JJ, Bosch RJ, Lalama CM, et al. mT-cell responses targeting HIV Nef uniquely correlate with infected cell frequencies after long-term antiretroviral therapy. Plos Pathogens. 13: e1006629. PMID 28931091 DOI: 10.1371/Journal.Ppat.1006629 |
0.768 |
|
2017 |
Pollack RA, Jones RB, Pertea M, Bruner KM, Martin AR, Thomas AS, Capoferri AA, Beg SA, Huang SH, Karandish S, Hao H, Halper-Stromberg E, Yong PC, Kovacs C, Benko E, et al. Defective HIV-1 Proviruses Are Expressed and Can Be Recognized by Cytotoxic T Lymphocytes, which Shape the Proviral Landscape. Cell Host & Microbe. 21: 494-506.e4. PMID 28407485 DOI: 10.1016/J.Chom.2017.03.008 |
0.755 |
|
2017 |
Raposo RA, de Mulder Rougvie M, Paquin-Proulx D, Brailey PM, Cabido VD, Zdinak PM, Thomas AS, Huang SH, Beckerle GA, Jones RB, Nixon DF. IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis. Jci Insight. 2: e85811. PMID 28097226 DOI: 10.1172/jci.insight.85811 |
0.733 |
|
2016 |
Jones RB, Mueller S, O'Connor R, Rimpel K, Sloan DD, Karel D, Wong HC, Jeng EK, Thomas AS, Whitney JB, Lim SY, Kovacs C, Benko E, Karandish S, Huang SH, et al. A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes. Plos Pathogens. 12: e1005545. PMID 27082643 DOI: 10.1371/Journal.Ppat.1005545 |
0.778 |
|
Show low-probability matches. |